Significant suppression of Multiple Sclerosis inthe Mouse EAE Model Using the PrC-210 Aminothiol

Written By Obvia

Link

Fahl WE, Fahl BL, Goesch SR, Goesch HR, Goesch TR.

International Journal of Molecular Sciences. 2025; 26:10597.

Obvia
Previous

Intravenous and Oral NOAEL Doses of the New PrC-210 Aminothiol in Swine and Dose Equivalency in Humans to Enable Clinical Trials
Next

A New Sensitive derivatization Assay of PrC-210 in Plasma and Tissues Using Liquid Chromatography Coupled with Tandem Mass Spectrometry